Squamous Cell Cancer of Head and Neck (SCCHN): Clinical Trials

9 trials for Squamous Cell Cancer of Head and Neck (SCCHN), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 2 not yet recruiting, 2 terminated, 1 completed. 4 Not applicable, 3 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 2, Recruiting 2
Phase 13Terminated 2, Recruiting 1
Phase 22Terminated 2
Phase 31Recruiting 1

Follow Squamous Cell Cancer of Head and Neck (SCCHN): new trials by email Literature Review of Squamous Cell Cancer of Head and Neck (SCCHN) trials Research Report on Squamous Cell Cancer of Head and Neck (SCCHN)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tumoral Versus Luminal Microbiome in Head and Neck Squamous Cell Carcinoma
Tissue and secretion sampling via biopsy - Squamous Cell Cancer of Head and Neck (SCCHN)
Not applicableNot yet recruitingCentre Hospitalier Sud Francilien1202026-10-012026-09-09
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Nivo800, Nivolumab - Hnscc, Head and Neck
Phase 1RecruitingVanderbilt-Ingram Cancer Center402026-07-032026-10-16
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
ExAblate Neuro - Head Neck Cancer, Squamous Cell Cancer of Head and Neck (SCCHN)
Not applicableRecruitingUniversity of Virginia202026-02-152026-02-12
Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck
Multimodal approach - Squamous Cell Cancer of Head and Neck (SCCHN)
Not applicableNot yet recruitingCentre Henri Becquerel1522025-12-012025-12-02
Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer
Daily adaptive radiation therapy, Image guided radiation therapy - Squamous Cell Cancer of Head and Neck (SCCHN)
Not applicableRecruitingUniversity Health Network, Toronto502025-10-152026-03-04
Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
Cisplatin - Squamous Cell Cancer of Head and Neck (SCCHN)
Phase 3RecruitingSun Yat-sen University3862025-08-152026-03-23
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
TAK-500, Pembrolizumab, Tocilizumab - Pancreatic Cancer, Hepatocellular Cancer
Phase 1 / Phase 2TerminatedTakeda612022-04-142026-01-22
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
TAK-186 - Squamous Cell Cancer of Head and Neck (SCCHN), Non-small Cell Lung Cancer (NSCLC)
Phase 1 / Phase 2TerminatedTakeda952021-03-082026-09-24
Skin Cancer Among Outdoor Workers
Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin
CompletedAssuta Medical Center100002018-01-012026-09-21

Narrower conditions

Head and Neck Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Breast Neoplasms (1)  ·  Cancer Pain (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Kidney Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Mesothelioma (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Carcinoma (3)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Lung Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)

Interventions

Cisplatin (1)  ·  Dexamethasone (1)  ·  Histocompatibility Testing (1)  ·  Nivolumab (1)  ·  Radiotherapy, Image-Guided (1)  ·  pembrolizumab (1)  ·  tocilizumab (1)

Sponsors

Takeda (2)  ·  Assuta Medical Center (1)  ·  Centre Henri Becquerel (1)  ·  Centre Hospitalier Sud Francilien (1)  ·  Sun Yat-sen University (1)  ·  University Health Network, Toronto (1)  ·  University of Virginia (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (4)  ·  France (2)  ·  Australia (1)  ·  Canada (1)  ·  China (1)  ·  Israel (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Eben Rosenthal, MD (1)  ·  William J Elias, MD (1)